“At $4, this is a dream stock at a bargain price …”
Tim Fields is telling us that the next big wave will be personalized medicine, and using genetic testing to customize treatments. We’ve heard that before from several newsletter editors, and it has been an investment theme for years. Will this little stock really revolutionize medicine and lead to untold riches for investors? First, I’ve got to figure out who it is for you.